Global Biomaterials Market Analysis and Forecast, 2021-2031 –

DUBLIN – (COMMERCIAL THREAD) – The report “Biomaterials Market – A Global and Regional Analysis: Focus on Applications, Product Types and Countries – Analysis and Forecast, 2021-2031” has been added to offer.

The global biomaterials market was valued at $ 122.92 billion in 2020 and is expected to reach $ 725.88 billion by 2031, with a CAGR of 17.98% between 2021 and 2031.

The main product categories by type include metal-based biomaterials, polymer-based biomaterials, ceramic-based biomaterials, natural-based biomaterials, inorganic glass-based biomaterials, radiopaque biomaterials, regenerative biomaterials, combinations of hybrid biomaterials.

In addition, the main applications include cardiovascular, orthopedic, ophthalmic, dental, wound healing, plastic surgery, neurological / central nervous system (CNS), tissue engineering and others.

The biomaterials market is driven by a number of factors such as superior properties of biomaterials, increasing government funds / aid for research purposes, increasing wound healing therapies and plastic surgeries, increasing aging / geriatric population, increasing prevalence of cardiovascular disease, increasing awareness of regenerative medicine, increasing orthopedic disorders and increasing demand for implantable devices.

However, biocompatibility issues, strict safety regulations, and limitations of biomaterial products are hampering the growth of the biomaterials market. The increase in obesity, the introduction of biomaterials in cancer research, increased patient awareness and improved lifestyles in growing economies such as India, China and Korea. South should create opportunities in the biomaterials market.

Market segmentation

Biomaterials Market by Application

Among the various applications of biomaterials, cardiovascular dominates the market and is expected to be the largest application during the forecast period.

The growing use of biomaterials in the cardiovascular applications segment is primarily driven by its biocompatibility, as the biomaterials come into contact with blood, vascular endothelial cells, fibroblasts and myocardium, as well as a number of other cells. and a cell matrix material.

Biomaterials used in the cardiovascular system include materials such as metals and polymers. The use of biomaterials in the cardiovascular system can be classified into temporary internal, temporary external and permanent internal devices.

Biomaterials Market by Product

Among the various types of biomaterials products, metal-based biomaterials dominate the market and are expected to be the most prominent product type during the forecast period. The predominance of metal-based biomaterials is attributed to wide use in biomaterial applications such as cardiovascular, orthopedic, ophthalmic, dental.

From simple wires, rods, pins, screws to fracture fixation plates and total joint prostheses (artificial joints) for hips, knees, shoulders and ankles, metals are used in all applications, including surgery maxillofacial, cardiovascular surgery and dental materials, etc. Metal-based biomaterials include stainless steel, titanium and commercially pure titanium alloys, cobalt and chromium alloys, gold, silver, magnesium, and nitinol.

Biomaterials market by region

Demand for biomaterials varies by region. The biomaterials market holds a large share in various countries in North America, Asia-Pacific and Japan, Europe, UK, China and the rest of the world, including North America should be the largest region in the world. biomaterials market during the forecast period.

Industrial advancements, significant investments in dedicated R&D facilities and the development of various application products requiring biomaterials are some of the major drivers currently propelling the growth of the North American biomaterials market. Moreover, owing to the large-scale production of biomaterials as well as technological advancements in technology, the global biomaterials market is expected to grow at a steady rate.

Key questions addressed in the report

  • What are the main drivers and challenges of the global biomaterials market?

  • How does the supply chain work in the global biomaterials market?

  • What type of product is expected to experience the maximum growth in demand in the global biomaterials market during the period 2021-2031?

  • What are the main application areas for which biomaterials could see high demand during the forecast period 2021-2031?

  • Who are the main suppliers of biomaterials in different countries and regions?

  • How is the industry expected to evolve over the forecast period 2021-2031?

  • What are the key offerings of leading manufacturers in the global biomaterials market?

  • Which regions and countries are leading in terms of biomaterial consumption, and which of them are expected to experience strong growth in demand from 2021 to 2031?

  • What are the key characteristics of consumers in various countries in the Global Biomaterials Market?

  • What are the main patents filed in the field of biomaterials?

  • What are the main development strategies implemented by the main players to support the competitive market?

  • What is the competitive strength of major players in the global biomaterials market based on their recent developments, product offerings, and regional presence?

  • Who are the major players (along with their detailed analyzes and profiles, including their company snapshots, key products and services, and strengths and weaknesses analyzes) in the market?

Market growth drivers

  • Increase in government funds / support for research purposes

  • Increase in plastic surgery and wound healing therapies

  • Growing aging / geriatric population

  • Increased prevalence of cardiovascular disease

  • Increase in orthopedic disorders

  • Growing demand for implantable devices

  • Increased awareness of regenerative medicine

Market challenges

  • Biocompatibility issues, safety and strict regulations

  • Limitations of Biomaterials Products

Market opportunities

  • Increased obesity

  • Patient awareness and lifestyle improvement in emerging economies

  • Introduction of biomaterials in cancer research

Key companies profiled


  • Carpenter Technology Company

  • Celanese Company

  • Collagen Solutions Plc

  • Corbion SA

  • Covestro SA

  • DSM

  • Evonik Industries

  • Zimmer Biomet

  • Wright Medical Group NV

  • Mitsubishi Chemical Holdings Corporation

  • Riton Biomaterial Co., Ltd.

  • Berkeley Advanced Biomaterials Inc

  • BBS-Oyj Bioactive Bone Substitutes

  • Bioretec SA

For more information on this report, visit

Comments are closed.